-
EP1652840
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1652840
| EP1652840 - (-)-(S)-N-(.alpha.-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.11.2007 Database last updated on 12.10.2024 | Most recent event Tooltip | 02.11.2007 | Application deemed to be withdrawn | published on 05.12.2007 [2007/49] | Applicant(s) | For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza P.O. Box 7929 Philadelphia, PA 19101 / US | [N/P] |
| Former [2006/18] | For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza, P.O. Box 7929 Philadelphia, Pennsylvania 19101 / US | Inventor(s) | 01 /
Sisko, Joseph 180 Logan Drive Hatfield, PA 19440 / US | 02 /
Mellinger, Mark GlaxoSmithKline PH R&D 1250 S. Collegeville Road P.O. Box 5089 Pennsylvania 19426 / US | 03 /
Kolwalski, Conrad 1724 Jennings Way Paoli, PA 19301 / US | [2006/30] |
| Former [2006/18] | 01 /
Sisko, Joseph 180 Logan Drive Hatfield, PA 19440 / US | ||
| 02 /
Mellinger, Mark 711 Wexford Way Telford, PA 18969 / US | |||
| 03 /
Kolwalski, Conrad 1724 Jennings Way Paoli, PA 19301 / US | Representative(s) | Thornley, Rachel Mary, et al GSK Legal & Compliance - Global Patents 79 New Oxford Street London WC1A 1DG / GB | [N/P] |
| Former [2006/18] | Thornley, Rachel Mary, et al GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 06075241.7 | 17.09.1998 | [2006/18] | Priority number, date | US19970059303P | 17.09.1997 Original published format: US 59303 P | [2006/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1652840 | Date: | 03.05.2006 | Language: | EN | [2006/18] | Type: | A3 Search report | No.: | EP1652840 | Date: | 17.05.2006 | [2006/20] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 31.03.2006 | Classification | IPC: | C07D215/12, C07D215/20, C07D215/38 | [2006/18] | CPC: |
C07D215/50 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2006/18] | Extension states | RO | 03.02.2006 | SI | 03.02.2006 | Title | German: | (-)-(S)-N-(.alpha.-Ethylbenzyl)-3-hydroxy-2-phenylchinolin-4-carboxamid | [2006/18] | English: | (-)-(S)-N-(.alpha.-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide | [2006/18] | French: | (-)-(S)-N-(.alpha.-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide | [2006/18] | Examination procedure | 03.02.2006 | Examination requested [2006/18] | 04.12.2006 | Despatch of a communication from the examining division (Time limit: M06) | 15.06.2007 | Application deemed to be withdrawn, date of legal effect [2007/49] | 23.07.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/49] | Parent application(s) Tooltip | EP98947099.2 / EP1017676 | Fees paid | Renewal fee | 03.02.2006 | Renewal fee patent year 03 | 03.02.2006 | Renewal fee patent year 04 | 03.02.2006 | Renewal fee patent year 05 | 03.02.2006 | Renewal fee patent year 06 | 03.02.2006 | Renewal fee patent year 07 | 03.02.2006 | Renewal fee patent year 08 | 08.09.2006 | Renewal fee patent year 09 | 05.09.2007 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [DX]WO9532948 (SMITHKLINE BEECHAM FARMA [IT], et al) [DX] 1 * page 4, Formula (Ia) * * page 5, line 18 * * page 38, general description of Table 3 * * page 46, TAble 3, Example 85 * * claim 11 * |